These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33059497)

  • 1. Update on: effects of anti-diabetic drugs on bone metabolism.
    Mabilleau G; Bouvard B
    Expert Rev Endocrinol Metab; 2020 Nov; 15(6):415-430. PubMed ID: 33059497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of anti-diabetic drugs on bone metabolism: Evidence from preclinical and clinical studies.
    Adil M; Khan RA; Kalam A; Venkata SK; Kandhare AD; Ghosh P; Sharma M
    Pharmacol Rep; 2017 Dec; 69(6):1328-1340. PubMed ID: 29132091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone health in diabetes: considerations for clinical management.
    Adami S
    Curr Med Res Opin; 2009 May; 25(5):1057-72. PubMed ID: 19292601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes and fracture healing: the skeletal effects of diabetic drugs.
    Simpson CM; Calori GM; Giannoudis PV
    Expert Opin Drug Saf; 2012 Mar; 11(2):215-20. PubMed ID: 22145960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diabetes increases the risk of fractures].
    Starup-Linde J; Karahasanovic A; Vestergaard P; Eiken P
    Ugeskr Laeger; 2015 Nov; 177(49):V08150663. PubMed ID: 26651553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The placebo response of injectable GLP-1 receptor agonists vs. oral DPP-4 inhibitors and SGLT-2 inhibitors: a systematic review and meta-analysis.
    de Wit HM; Te Groen M; Rovers MM; Tack CJ
    Br J Clin Pharmacol; 2016 Jul; 82(1):301-14. PubMed ID: 26935973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoporosis and risk of fracture in patients with diabetes: an update.
    Montagnani A; Gonnelli S; Alessandri M; Nuti R
    Aging Clin Exp Res; 2011 Apr; 23(2):84-90. PubMed ID: 21743287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diabetes Mellitus and bone metabolism].
    Okazaki R
    Clin Calcium; 2011 May; 21(5):669-75. PubMed ID: 21532115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes and bone health.
    Antonopoulou M; Bahtiyar G; Banerji MA; Sacerdote AS
    Maturitas; 2013 Nov; 76(3):253-9. PubMed ID: 23628280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of fracture caused by anti-diabetic drugs in individuals with type 2 diabetes: A network meta-analysis.
    Tsai WH; Kong SK; Lin CL; Cheng KH; Cheng YT; Chien MN; Lee CC; Tsai MC
    Diabetes Res Clin Pract; 2022 Oct; 192():110082. PubMed ID: 36122867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes Drug Effects on the Skeleton.
    Chandran M
    Calcif Tissue Int; 2017 Feb; 100(2):133-149. PubMed ID: 27815568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Managing and maintaining bone mineral density in diabetes patients with pharmacotherapy.
    Fixen CW; Fixen DR
    Expert Opin Pharmacother; 2017 Dec; 18(18):2001-2006. PubMed ID: 29172834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the cardiovascular risk with non-insulin antidiabetic drugs.
    Athyros VG; Imprialos K; Stavropoulos K; Sahinidis A; Doumas M
    Expert Opin Drug Saf; 2019 Mar; 18(3):241-251. PubMed ID: 30810055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone effects of glitazones and other anti-diabetic drugs.
    Rejnmark L
    Curr Drug Saf; 2008 Sep; 3(3):194-8. PubMed ID: 18691001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type 2 diabetes and risk of heart failure: a systematic review and meta-analysis from cardiovascular outcome trials.
    Giugliano D; Maiorino MI; Longo M; Bellastella G; Chiodini P; Esposito K
    Endocrine; 2019 Jul; 65(1):15-24. PubMed ID: 31028667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular effects of anti-diabetes drugs.
    Younk LM; Lamos EM; Davis SN
    Expert Opin Drug Saf; 2016 Sep; 15(9):1239-57. PubMed ID: 27268470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagon-like peptide-1 receptor agonists and risk of bone fracture in patients with type 2 diabetes: A meta-analysis of randomized controlled trials.
    Cheng L; Hu Y; Li YY; Cao X; Bai N; Lu TT; Li GQ; Li N; Wang AN; Mao XM
    Diabetes Metab Res Rev; 2019 Oct; 35(7):e3168. PubMed ID: 30974033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 2 diabetes and the skeleton: new insights into sweet bones.
    Shanbhogue VV; Mitchell DM; Rosen CJ; Bouxsein ML
    Lancet Diabetes Endocrinol; 2016 Feb; 4(2):159-73. PubMed ID: 26365605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of thiazolidinediones on bone loss and fracture.
    Murphy CE; Rodgers PT
    Ann Pharmacother; 2007 Dec; 41(12):2014-8. PubMed ID: 17940125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diabetes mellitus and bone].
    Kanazawa I; Sugimoto T
    Clin Calcium; 2016 Aug; 26(8):1185-93. PubMed ID: 27461503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.